Coronary heart disease and peripheral arterial occlusive disease, with particular reference to myocardial infarction

MMW, Munchener Medizinische Wochenschrift
|February 13, 1976
PubMed

Insights

Coronary heart disease and peripheral arterial disease are linked systemic conditions. Many myocardial infarction patients also have peripheral arterial occlusive disease, highlighting the need for integrated treatment approaches.

Area of Science:

  • Cardiology
  • Vascular Medicine
  • Systemic Diseases

Background:

  • Coronary heart disease (CHD) and peripheral arterial vascular disease (PAVD) are manifestations of a systemic vascular disease.
  • The co-occurrence of these conditions impacts patient prognosis and treatment strategies.

Purpose of the Study:

  • To investigate the frequency and significance of concomitant coronary and peripheral arterial occlusive diseases.
  • To understand the relationship between these vascular conditions, particularly in patients with myocardial infarction (MI).

Main Methods:

  • Analysis of patient data from three studies involving individuals with manifest myocardial infarction.
  • Assessment of peripheral arterial occlusive disease (PAOD) in Fontaine's Stages I and II among MI patients.
  • Evaluation of coincident vascular disease in patients with CHD without infarction.

Main Results:

  • Among 193 MI patients, 176 (91.2%) exhibited coexisting PAOD (Fontaine's Stages I and II).
  • The frequency of combined coronary and peripheral vascular obstruction ranged from 65.9% to 94.1% across studies.
  • In patients with CHD without infarction, coincident disease in both vascular areas was observed in 87.9%.
  • Pre-infarction signs of PAOD were present in 27.8% to 33.3% of MI patients.

Conclusions:

  • Coronary and peripheral arterial occlusive diseases frequently coexist, indicating a shared systemic pathology.
  • The high prevalence of concurrent PAOD in MI patients underscores the importance of comprehensive vascular assessment.
  • Understanding these interrelationships is crucial for optimizing rehabilitation strategies in cardiovascular patients.

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Angina I: Introduction01:30

Angina I: Introduction

Definition and Symptoms: Angina (angina pectoris) is chest pain or discomfort caused by myocardial ischemia, which occurs when the heart muscle receives insufficient oxygen-rich blood. It typically manifests as pressing, squeezing, or crushing sensations in the chest and may radiate to the shoulders, arms, neck, jaw, or back.Primary Cause: In a healthy state, the coronary arteries can dilate (widen) to increase blood flow and meet the increased oxygen demand during physical activity or...